Daybreak

Eli Lilly's Mounjaro has skyrocketed to become India's second-best-selling drug, marking a significant victory in the weight-loss market. With a $1 billion investment for a new manufacturing hub in Hyderabad, the competition is heating up as local pharma prepares for cheaper GLP-1 generics. The conversation dives into why diabetes medications have morphed into weight-loss wonders and the unique properties that set Mounjaro apart scientifically. Yet, hurdles like regulatory compliance and skepticism loom large in this evolving landscape.

Deloitte's recent AI misstep leads to a surprising global rollout of Anthropic's Claude, showcasing a bold new logic among the Big Four. With audit work slowing and regulations tightening, firms like PwC and EY prioritize speed and visibility over accuracy. As they rush to adopt AI, industry sameness emerges, prompting a shift in competition from precision to performance. Future differentiation may hinge on governance and traceability, as firms seek to navigate the evolving credibility economy.

Explore the rollercoaster journey of Fogg deodorant, rising to fame with its unique no-gas formula. Delve into the complexities of KKR's $600 million acquisition and the ensuing power struggle with the Patel brothers. Discover how budget cuts and a focus on traditional brand strategies caused Fogg's market dominance to wane. With new product launches faltering and a leadership shake-up on the horizon, the future of Vini Cosmetics hangs in the balance. Will they innovate or double down on their classic brand?

Against a backdrop of a sluggish market, an online brokerage has soared to a valuation of $1.2 billion. Dhan's focus on experienced traders has set it apart, attracting nearly a million users. With a strategic pivot towards derivatives, it has turned losses into impressive profits. Dhan’s heavy tech investment and lean marketing strategy have fueled its growth. Analysts believe its loyal user base will help it navigate challenges ahead, making it a standout player during turbulent times.

A tiny AI startup is revolutionizing IT sales by decoding buyer personalities and communication styles using public data. This innovative approach aims to give salespeople a competitive edge in closing billion-dollar deals. The founder discusses the challenges of gaining buyer trust in a crowded market. As generative AI reshapes client expectations, the company focuses on automating pre-sales research to save time. Concerns about data privacy are addressed, emphasizing a commitment to ethical sourcing. Future developments include company-level insights and an AI sales coach.

PhonePe is gearing up for a $15 billion IPO, presenting a strong case compared to Paytm's rocky debut. With narrowing losses and a clean regulatory record, it appears more stable, though challenges like subsidy cuts loom. Walmart's role as a major investor adds weight, but questions about market conditions and risk remain. The upcoming UPI market-share cap could also impact its growth strategy. Industry insights reveal how PhonePe aims to diversify its revenues and attract retail investors despite potential pitfalls.

The podcast dives into the fierce competition among FMCG giants for a slice of the lucrative spice market in India. Following 2020, companies like ITC and Tata are paying top dollar for spice brands, spurred by soaring margins. Orkla’s strategic moves and recent IPO signal a pivotal moment in the spice wars. However, the market faces challenges, including regional tastes, brand loyalty, and issues of adulteration. Discover how the shift from unorganized to packaged spices is reshaping consumer habits and the industry landscape.

Discover the struggles of Kashmiri saffron farmers as they recount plummeting yields and lost fields. Unpack the broken value chains that prevent them from benefiting from rising retail prices. Learn how a GI tag hasn’t halted adulteration and how Iran's strategies dominate 90% of the global market. Explore innovative solutions like indoor farming that show promise for revival. Experts highlight the need for strategic investments and branding to reclaim Kashmir's saffron identity and market share.

India's beverage landscape is shifting dramatically with the rise of zero-sugar sodas, spurred by Reliance's budget-friendly Campa Cola. Coke and Pepsi are compelled to restructure their pricing strategies, emphasizing a significant market change. The economics behind artificial sweeteners reveal potential margins but also raise health concerns, questioning if low-sugar drinks are truly beneficial. As deceptive labels emerge and health risks associated with sweeteners like erythritol and aspartame come to light, consumers face a complex choice between price and health in this evolving market.

Nooha Boobere, a sharp reporter at The Ken, dives into Swiggy's drastic changes post-IPO, revealing how CEO Sriharsha Majety's leadership is pushing for a cultural shift from a meticulous doc culture to a fast-paced, risk-taking ethos. She discusses the influx of ex-Flipkart talent like Amitesh Jha and the challenges Swiggy faces against rivals Blinkit and Zepto. Nooha highlights the need for profitability and strategic adjustments, emphasizing that Swiggy's adaptability could be crucial for reclaiming its edge in the quick-commerce arena.